Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infectionsSebastian Schneeweiß, Brian Bressler, Joy Lee et al.|Alimentary Pharmacology & Therapeutics|2009Cited by 214
968 Infliximab Use in Patients with Inflammatory Bowel Disease and the Risk of Serious Bacterial InfectionsBrian Bressler, Sebastian Schneeweiß, Joshua R. Korzenik et al.|Gastroenterology|2008Cited by 4